SEC Form 4 · accession 0001567619-19-006067
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Business Operations
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2019 | S | 1,019 | $57.9218 | D | 36,694 | D | |
| Common StockF1 | Mar 1, 2019 | S | 2,024 | $58.20 | D | 34,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- F2The price reported is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.52 to $58.49, inclusive.